HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roshan M Borkar Selected Research

balofloxacin (Q 35)

9/2018Identification and structural characterization of in vivo metabolites of balofloxacin in rat plasma, urine and feces samples using Q-TOF/LC/ESI/MS/MS : In silico toxicity studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roshan M Borkar Research Topics

Disease

4Neoplasms (Cancer)
01/2022 - 06/2016
3Inflammation (Inflammations)
01/2022 - 05/2014
2Type 2 Diabetes Mellitus (MODY)
01/2022 - 11/2016
1Body Weight (Weight, Body)
03/2022
1Cardiac Arrhythmias (Arrythmia)
02/2022
1Angina Pectoris
02/2022
1Disease Progression
01/2022
1Diabetes Complications
02/2021
1Hemolysis
08/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2019
1Triple Negative Breast Neoplasms
01/2019
1Urinary Tract Infections (Urinary Tract Infection)
09/2018
1Breast Neoplasms (Breast Cancer)
11/2017
1Wounds and Injuries (Trauma)
01/2017
1Cardiomegaly (Heart Hypertrophy)
01/2017
1Necrosis
01/2017
1Vitamin D Deficiency
11/2016
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2016
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
10/2016
1Cardiotoxicity
01/2016
1Prostatic Neoplasms (Prostate Cancer)
06/2014
1Mitochondrial Diseases (Mitochondrial Disease)
05/2014
1Communicable Diseases (Infectious Diseases)
08/2012
1Tuberculosis (Tuberculoses)
08/2012

Drug/Important Bio-Agent (IBA)

5Pharmaceutical PreparationsIBA
09/2018 - 08/2012
2Vitamin DFDA LinkGeneric
01/2022 - 11/2016
1ParabensIBA
03/2022
1PrenylamineIBA
02/2022
1Agammaglobulinaemia Tyrosine KinaseIBA
01/2022
1acalabrutinibIBA
01/2022
1Aldehyde Reductase (Aldose Reductase)IBA
02/2021
1fidarestatIBA
02/2021
1LipidsIBA
08/2020
1LigandsIBA
08/2020
1NiclosamideFDA Link
05/2019
1AfatinibIBA
03/2019
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1Anti-Bacterial Agents (Antibiotics)IBA
09/2018
1balofloxacin (Q 35)IBA
09/2018
1poly(lactide) (polylactic acid)IBA
11/2017
1glycolic acid (glycolate)IBA
11/2017
1betadex (beta-cyclodextrin)IBA
11/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2017
1Hydroxyl RadicalIBA
11/2017
1allyl methyl sulfideIBA
01/2017
1CalciumIBA
01/2017
1Adenosine Triphosphatases (ATPase)IBA
01/2017
1Proteins (Proteins, Gene)FDA Link
01/2017
1SteroidsIBA
01/2017
1SulfurIBA
01/2017
1EnzymesIBA
01/2017
1Isoproterenol (Isoprenaline)FDA LinkGeneric
01/2017
1sulfoxideIBA
01/2017
1hydroxide ionIBA
11/2016
1silodosinFDA Link
10/2016
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
06/2016
1FlavonoidsIBA
01/2016
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2016
1Biomarkers (Surrogate Marker)IBA
01/2016
1baicaleinIBA
01/2016
1AndrogensIBA
06/2014
1nilutamide (Nilandron)FDA Link
06/2014
1NADH DehydrogenaseIBA
05/2014
1naringinIBA
05/2014
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
05/2014
1Gentamicins (Gentamicin)FDA LinkGeneric
05/2014
1Succinate Dehydrogenase (Fumarate Reductase)IBA
05/2014
1Moxifloxacin (Avelox)FDA Link
08/2012
1FluoroquinolonesIBA
08/2012

Therapy/Procedure

1Therapeutics
01/2022